Collegium Pharmaceutical Stock Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for Collegium Pharmaceutical stock have an average target of 51.4, with a low estimate of 37 and a high estimate of 60. The average target predicts an increase of 56.66% from the current stock price of 32.81.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$37	$51.4	$56	$60
Change	+12.77%	+56.66%	+70.68%	+82.87%

* Price targets were last updated on Mar 20, 2026.

Analyst Ratings

The average analyst rating for Collegium Pharmaceutical stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	4	4	4	4	4	3
Buy	0	1	1	1	1	1
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	6	6	6	6	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Brandon Folkes HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $60	Strong Buy	Reiterates	$60	+82.87%	Mar 20, 2026
Serge Belanger Needham	Needham	Strong Buy Reiterates $54 → $56	Strong Buy	Reiterates	$54 → $56	+70.68%	Mar 19, 2026
Serge Belanger Needham	Needham	Strong Buy Maintains $56 → $54	Strong Buy	Maintains	$56 → $54	+64.58%	Feb 26, 2026
Glen Santangelo Barclays	Barclays	Buy Maintains $58 → $56	Buy	Maintains	$58 → $56	+70.68%	Jan 9, 2026
Brandon Folkes HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $46 → $60	Strong Buy	Reiterates	$46 → $60	+82.87%	Jan 9, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

843.09M

from 780.57M

8.01%

from 780.57M

Revenue Next Year

802.28M

from 843.09M

-4.84%

from 843.09M

EPS This Year

7.44

from 1.73

328.80%

from 1.73

EPS Next Year

6.52

from 7.44

-12.41%

from 7.44

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	276.87M	463.93M	566.77M	631.45M	780.57M	843.09M	802.28M
Revenue Growth	-10.69%	67.57%	22.17%	11.41%	23.62%	8.01%	-4.84%
EPS	1.86	-0.74	1.29	1.86	1.73	7.44	6.52
EPS Growth	144.25%	-	-	43.56%	-6.56%	328.80%	-12.41%
Forward PE	-	-	-	-	-	4.41	5.04
No. Analysts	-	-	-	-	-	8	8

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	907.4M	998.6M
Avg	843.1M	802.3M
Low	789.7M	611.4M

Revenue Growth

Revenue Growth	2026	2027
High	16.3%	18.4%
Avg	8.0%	-4.8%
Low	1.2%	-27.5%

EPS Forecast

EPS	2026	2027
High	7.93	8.19
Avg	7.44	6.52
Low	6.80	4.32

EPS Growth

EPS Growth	2026	2027
High	357.3%	10.1%
Avg	328.8%	-12.4%
Low	292.0%	-41.9%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.